Claim Missing Document
Check
Articles

Found 7 Documents
Search

KAJIAN SINKRONISASI ANTARA PERENCANAAN DAN KEBUTUHAN ALAT KESEHATAN DI RUMAH SAKIT TINGKAT III TNI AL DI ERA JKN PERIODE 2020 Ningsih, Ita Trismiati; Delina Hasan; Prih Sarnianto
Fair Value: Jurnal Ilmiah Akuntansi dan Keuangan Vol. 4 No. 3 (2021): FairValue : Jurnal Ilmiah Akuntansi dan Keuangan
Publisher : Departement Of Accounting, Indonesian Cooperative Institute, Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (188.735 KB) | DOI: 10.32670/fairvalue.v4i3.727

Abstract

Health equipment will be effective if it is adjusted to the needs of each hospital, with increasing servicedemands, incomplete medical devices can cause problems in service, and become complaints of patientswho come for treatment at the hospital, including JKN patients. within the Indonesian Navy. This studyaims to determine the synchronization between planning and the need for medical devices at the TNI ALLevel III Hospital in 2020. This study used a quantitative descriptive method with retrospective datacollection on medical devices at five Level III TNI AL Hospitals, namely the TNI AL Hospital Dr. .Komang Makes (Belawan, North Sumatra), Dr. Oepomo (Surabaya, East Java), Samuel J. Moeda(Kupang, East Nusa Tenggara), Marine Ewa Pangalila (Surabaya, East Java), Merauke (Merauke). Theanalysis shows that planning guidelines, sources of funds, coordination, planning preparation, planningmethods, planning documents, distribution are in accordance with Minister of Defense Regulation No. 11of 2014. Thus, it can be concluded that the condition of medical devices in five level III hospitals of theIndonesian Navy in 2020 is appropriate in terms of the Minister of Defense Regulation No. 11 of 2014,there is a synchronization between planning and the need for medical equipment in the JKN era, and theTNI AL Level III Hospital is ready to cooperate with BPJS Health.
Kualitas dan Potensi Beberapa Kaplet/Tablet/Kapsul Antibiotik Pemenang e-Katalog 2017, Obat Sejenis Pengganti dan Originatornya Prih Sarnianto; Syarmalina Syarmalina; Ferannisa Firdaus; Rike Farahiyah; Mustiko Aji Punto Baskoro; Esa Aulia Rizkita
JURNAL ILMU KEFARMASIAN INDONESIA Vol 20 No 1 (2022): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v20i1.1208

Abstract

The price of drugs that win the e-Catalogue tender has long been considered too low by some pharmaceutical companies, and some even below their production cost. On the other hand, the fact that only pharmaceutical products with BPOM distribution licenses are eligible for the price tender, the quality of such e-Catalogue winners should not be of concern. This study aimed to evaluate the quality of several items of antibiotic products, an important drug category that can cause serious impacts if its quality is compromised. Samples used in the study were product items with the highest demands: Amoxicillin 500 mg, tetracycline 500 mg, cefadroxil 500 mg, and ciprofloxacin 500mg listed in the e-Catalogue 2017 as well as their generic and branded generic (OND) alternatives, and its respective originators. The quality parameters of the samples were evaluated according to the Indonesian Pharmacopoeia 5th Edition (FI-V). Antibiotic potency assays were conducted by using the Plate-Cylinder Method with S. aureus ATCC 25922 and E. coli ATCC 6538 as the testing bacteria. The results showed that all samples met the FI-V requirements on antibiotic content, weight uniformity, disintegration time, and dissolution. However, antibiotic potency of the e-Catalogue 2017 winners tend to be lower than their generic and OND alternatives as well as their respective originators, with a wide disparity: 10.3–18.2 percentage points, or a relative disparity of 12.0–26.4%, except for amoxicillin 500 mg caplet, in the assays using S. aureus. In conclusion, tetracycline 500 mg, cefadroxil 500mg, and ciprofloxacin 500 mg caplets/tablets/capsules listed in the e-Catalogue 2017 contain active pharmaceutical ingredients of lower qualities than their more expensive alternatives
Analysis of Treatment Profile, Direct Medical Costs, and Quality of Life in Hemodialysis Patients in Hospital X in Banten Lucky Dita Agustiansyah; Prih Sarnianto; Yusi Anggraini
Budapest International Research and Critics Institute (BIRCI-Journal): Humanities and Social Sciences Vol 4, No 3 (2021): Budapest International Research and Critics Institute August
Publisher : Budapest International Research and Critics University

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33258/birci.v4i3.2207

Abstract

Chronic kidney failure (CRF) is one of the world's health problems because its prevalence continues to increase. There was a 4-fold increase in new patients and a 16-fold increase in active patients from 2007 to 2015. Payments made by BPJS use the INA-CBGs system. This study was conducted to see the feasibility of the real treatment profile compared to the Pernefri standard (Indonesian Nephrology Association) and the cost consequences compared to the Ina-CBGs rate, as well as to see the factors that affect the patient's quality of life. This type of research is an observational study with a cross-sectional design. Treatment profile data were taken retrospectively from medical records. Direct cost data were taken retrospectively from patient treatment documents. Patient's quality of life data was collected prospectively from in-person interviews using a validated EQ-5D questionnaire. The results showed that the sexes were 43 males and 35 females, with the largest age range> 50 years, retirees and IRT, junior high school / high school education, the most marital status was married. Based on the treatment profile of the incompatibility of EPO therapy with a Hb between 8 g, dL-10 g / dL was not given EPO. Based on the calculation of real medical costs of Rp. 660,529, which is less than the ideal medical cost of Rp. 778,786 and the tariff for Ina-CBG is Rp. 879,100. Quality of life of patients with CRF have a sufficient quality of life with a mean value of 63.01% (p <0.05, Linear regression)
The Effects of Counseling and Drug Information Services by Pharmacist to Medication Adherence and Therapy Outcomes on Sciatica Patients at Dr. Suyoto Hospital, Jakarta Farida Ariyani; Prih Sarnianto; Nurita Andayani
Jurnal Delima Harapan Vol 8 No 1 (2021)
Publisher : AKADEMI KEBIDANAN HARAPAN MULYA PONOROGO

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31935/delima.v8i1.124

Abstract

People suffered from sciatica, pain along the sciatic nerve, require therapy up to 4 months or longer to achieve controlled-pain. The main treatment for sciatica is physiotherapy; medication is only secondary therapy. This quasi-experimental study aimed to investigate the effects of counseling and drug information services (DIS) by pharmacist on medication adherence and duration of therapy. In the study conducted in March‒July 2018, 128 ambulatory sciatica patients newly diagnosed at Dr. Suyoto Hospital, Jakarta, were divided randomly into two groups, each of 64 patients. The intervention group was given counseling and DIS by clinical pharmacists (3 times with interval of 4 weeks) as well as brochures. Primary data on medication adherence were obtained prospectively through interviews using a validated questionnaire, before the intervention and 4 weeks after the last counseling and DIS by clinical pharmacists. Secondary data (up to 16 weeks), including pain scores, were obtained from medical records and the patient administrative data. The results showed that sociodemographic characteristics as well as distribution of initial adherence and initial pain levels of the two groups were not significantly different (Mann-Whitney test, p>0.05). After the last intervention, the proportion of patients with high-adherence in the intervention group (12.5%) was higher than in the control group (6.3%), as was the proportion of patient achieved controlled-pain (84.4% versus 76.6%). The results of survival analysis showed that the duration of treatment by which 50% of patients achieved controlled-pain (median survival) was significantly shorter in the intervention group (85 days) than in the control group (92 days), while the probability of achieving controlled-pain (hazard ratio) in the intervention group was 1.7 times of that in the control group. In conclusion, counseling and DIS by pharmacist can improve the effectiveness of sciatica treatment, although the main therapy for the nerve pain is not medication.
Analisis Biaya Medis Langsung Pasien Hemodialisa di Rumah Sakit X Wilayah Bekasi Iin Ruliana Rohenti; Hesty Utami Rahmadaniati; Prih Sarnianto
PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia) Jurnal Pharmacy, Vol. 16 No. 02 Desember 2019
Publisher : Pharmacy Faculty, Universitas Muhammadiyah Purwokerto

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (865.229 KB) | DOI: 10.30595/pharmacy.v16i2.5731

Abstract

Pasien Penyakit Ginjal Kronik (PGK) tahap akhir diindikasikan untuk memperoleh terapi renal replacement therapy, yaitu dialisis. Dialisis yang dimaksud baik dialisis peritonial maupun hemodialisis. Pembiayaan PGK merupakan peringkat kedua pembiayaan  terbesar dari BPJS kesehatan setelah penyakit jantung. Tujuan penelitian ini adalah menganalisis pengobatan dan biaya rata-rata menurut perspektif rumah sakit dibandingkan dengan tarif INA CBGs pada pasien PGK yang menjalani hemodialisa rawat jalan di RS X. Jenis penelitian ini adalah penelitian observasional dengan pendekatan cross sectional (retrospektif) menggunakan dokumen rekam medis, data keuangan, dan data pengobatan pasien. Analisis biaya membandingkan biaya riil dengan biaya ideal menggunakan uji Wilcoxon. Data penelitian adalah data kuantitatif. Sampel penelitian ini berjumlah 74 pasien. Hasil penelitian ini menunjukkan biaya riil untuk satu kali kunjungan hemodialisa di RS X adalah sebesar Rp705.523,00. Besaran tarif INA CBGs untuk hemodialisa rumah sakit pemerintah kelas B adalah Rp879.100,00. Biaya ideal untuk manajemen terapi anemia  sebesar Rp1.056.946,00. Analisis biaya riil dengan ideal menyatakan perbedaan bermakna dengan nilai p<0,05 (p=0,018). Biaya riil lebih rendah dari pada tarif INA CBGs. Biaya ideal lebih tinggi daripada tarif INA CBGs.
Analisis Efektivitas Biaya Seftriakson sebagai Antibiotik Profilaksis Pada Seksio Sesarea: Dosis Tunggal Versus Dosis Berulang Bayu Pertiwi; Hesty Utami Ramadaniati; Prih Sarnianto; Dwirani Amelia
JURNAL ILMU KEFARMASIAN INDONESIA Vol 20 No 2 (2022): JIFI
Publisher : Fakultas Farmasi Universitas Pancasila

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35814/jifi.v20i2.1084

Abstract

The provision of single-dose prophylactic antibiotics within 30 to 60 minutes before caesarean has been highly recommended, yet its implementation in hospitals varies considerably. This research aimed to analyze the cost-effectiveness of prophylactic antibiotics given a single dose versus multiple doses during caesarean section surgery. A retrospective observational study with a crosssectional design involved pregnant women undergoing caesarean section and receiving a ceftriaxone single dose before surgery (Group 1) versus those receiving multiple ceftriaxone doses (Group 2). The study calculated direct medical costs (hospital perspective), with surgical site infection (SSI) as the effectiveness parameter. The chi-square test was used to compare SSI between the two groups. There were 806 patients (group 1) and A total of 250 patients (Group 2) met the inclusion criteria. Analysis of total cost revealed no significant difference between both groups (approximately IDR 13,000,000/patient), yet patients receiving prolonged Ceftriaxone were associated with significantly higher antibiotic costs (p-0.000). The study documented 1.2% SSI in Group 1 and 0.8% in Group 2 (p=0.742). Calculation of the incremental cost-effectiveness ratio found that an extra IDR 3,278,000 was needed to provide additional success to prevent SSI by administering multiple doses of ceftriaxone. In conclusion, a single dose prophylactic antibiotic provides comparable efficacy to a multiple-dose regimen, but at a lower cost.
Pengaruh Penerapan PROLANIS Pada Pasien Diabetes Mellitus Tipe 2 Di Puskesmas Kota Bekasi Lia Warti; Dian Ratih Laksmitawati; Prih Sarnianto
Jurnal Farmasi Indonesia Vol 19 No 2 (2022): Jurnal Farmasi Indonesia
Publisher : Fakultas Farmasi Universitas Setia Budi

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31001/jfi.v19i2.1481

Abstract

Prolanis is Chronic Disease Management Program; where this program is an integrated health service program and involves other parties such as BPJS, health facilities and patients. Clinical outcomes ultimately impact the quality of life and, in general, if the quality of life grows well, which is indicated by controlled glucose levels. The result of this research is to know the impact of applying Prolanis to measure the quality of life in type 2 Diabetes Mellitus patients at Pekayon Jaya Health Center and Pengasinan Health Center. The method used in this research is a cohort study with data analysis of SPSS version 24. The study was conducted on 80 patients consisting of 40 prolanis patients at Pekayon Jaya Health Center and 40 non-prolanis patients at Pengasinan Health Center within a period of 3 (three) months. Data on the level of knowledge and compliance were collected using a questionnaire. GDP data was taken from monthly patient control visits, and quality of life data was taken using the European Quality of Life-5 Dimension-5 Level (EQ-5D-5L) instrument and the conversion of health utility to the Indonesian value set. The result is there is a significant effect of applying prolanis program in prolanis and non-prolanis patients on the level of knowledge, compliance, and GDP in describing the quality of life. The utility value of prolanis patients was 0.945±0.101 higher than non-prolanis patients, 0.769±0.197. Based on the level of knowledge of prolanis and non-prolanis patients (34.35±2.13: 28.47±4.09), prolanis and non-prolanis patient compliance (6.38±1.66: 5.11±1.45), and fasting blood sugar values ​​of prolanis and non-prolanis patients (110.05±20.67 : 144.20±29.10). The application of Prolanis is said to have a considerable influence on the level of discipline, knowledge, and GDP to the quality of life of patients, both prolanis and non-prolanis.